Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
VIGL | Vigil Neuroscience, Inc. | President and CEO, Director | $3.6M | May 3, 2024 | ||
QTRX | Quanterix Corp | Director | $160K | Oct 2, 2024 | ||
ABSI | Absci Corp | Director | Jun 8, 2022 | |||
ACRV | Acrivon Therapeutics, Inc. | Director | Feb 8, 2024 | |||
SYRE | Spyre Therapeutics, Inc. | Director | Jun 22, 2023 | |||
AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Director | Nov 30, 2021 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|